Imanis Life Sciences is a biotechnology company focused on regenerative medicine, gene therapy, oncology, and oncolytic virotherapy research. The company provides two core research solution areas: products for oncolytic virus therapy studies and non-invasive imaging reagents for both in vitro and in vivo applications. Its portfolio is centered on high-quality reporter cell lines, lentiviral vectors and gene constructs, NIS- and VSV-specific antibodies, and a comprehensive collection of oncolytic virus resources, supporting translational and preclinical research in cancer biology and therapeutic development.

■ Product Portfolio

Vicbio Biotechnology Co., Ltd. provides the full range of Imanis Life Sciences products.

⇨ Inquire or Order immediately ⇦

1. Reporter Lentiviral Vectors and Plasmid Systems

Imanis Life Sciences offers a full range of reporter lentiviral vectors and supporting plasmid systems. Ready-to-use viral particles provide a safe and efficient solution for reporter gene delivery, especially for primary cells and other hard-to-transfect cell types. The company also supplies complete packaging plasmid systems for users who wish to produce lentiviral particles in-house.

2.Stable Cell Lines

The stable cell line portfolio is designed to support both in vitro and in vivo studies in oncology and immuno-oncology. Constitutive reporter cell lines expressing luciferase, fluorescent proteins, or NIS are suitable for applications such as in vitro drug screening and longitudinal tumor monitoring in live animal models. In addition, engineered tumor antigen cell lines with controlled expression of common cancer-associated antigens and therapeutic targets, including CD19, EGFR, and Her2, are available for target validation and therapy-related studies.

3. Oncolytic Virus Resources

Imanis Life Sciences provides a comprehensive oncolytic virus resource portfolio, including ready-to-use viral stocks for in vitro and in vivo research. These products are designed to support the development and evaluation of oncolytic virotherapy approaches across a range of experimental settings.

4. Antibodies

The company offers high-quality NIS antibodies compatible with Western blot, immunohistochemistry, immunofluorescence, and flow cytometry. It also provides multifunctional anti-VSV antibodies suitable for WB, IHC, IF, ELISA, flow cytometry, and VSV neutralization assays, supporting broad applications in virology and imaging-related research.

■ Product List